Yselty
·
- Prescription status not stated
- Hormones, such as thyroid and steroids
- Active substance
- Linzagolix choline
- Made by
- Theramex Ireland Limited
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Yselty is indicated in adult women of reproductive age for: - treatment of moderate to severe symptoms of uterine fibroids,- symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis (see section 5.1).
From the official label · 2026-09-30 · European Medicines Agency
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
SpainNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | Theramex Ireland Limited |
|---|---|
| Active substance | Linzagolix choline |
| Used in | Hormones, such as thyroid and steroids |
| Classification | H01CC04 · Hormones, such as thyroid and steroids |
| Additional monitoring ▼ | Yes — under additional monitoring (black triangle). Report suspected side effects. |
| Authorised on | 2022-06-14 |
| Last updated by the regulator | 2025-11-21 |
| EMA product number | EMEA/H/C/005442 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).